A NOVEL BIOMARKER RENALASE AND ITS RELATIONSHIP WITH ITS SUBSTRATES IN SCHIZOPHRENIA

Creative Commons License

Catak Z., Kocdemir E., UĞUR K., Yardim M., Sahin I., Kaya H., ...More

JOURNAL OF MEDICAL BIOCHEMISTRY, vol.38, no.3, pp.299-305, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 3
  • Publication Date: 2019
  • Doi Number: 10.2478/jomb-2018-0031
  • Journal Name: JOURNAL OF MEDICAL BIOCHEMISTRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.299-305
  • Erzincan Binali Yildirim University Affiliated: No

Abstract

Background: Schizophrenia, particularly the form related to excessive dopamine (DA), is a chronic psychotic disorder affecting millions of people worldwide. Renalase metabolizes its catecholamine (CA) substrates, including DA, suggesting that there might be an association between renalase levels and schizophrenia occurrence. Therefore, the current study aimed to evaluate the renalase and CA levels in the serum of patients with schizophrenia.